Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0001021408-02-004301
Filing Date
2002-03-28
Accepted
2002-03-28 00:00:00
Documents
2
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k405.txt 10-K405 157171
3 CONSENT OF INDEPENDENT AUDITORS dex231.txt EX-23.1 770
  Complete submission text file 0001021408-02-004301.txt   159623
Mailing Address 8540 COLONNADE CENTER DR SUITE 501 RALEIGH NC 27615
Business Address 8540 COLONNADE CENTER DR SUITE 501 RALEIGH NC 27615 9198621000
SALIX PHARMACEUTICALS LTD (Filer) CIK: 0001009356 (see all company filings)

EIN.: 943267443 | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-23265 | Film No.: 02591128
SIC: 2834 Pharmaceutical Preparations